ORIGINAL RESEARCH
Published on 13 Nov 2018
Biodegradable Nanoparticles Mediated Co-delivery of Erlotinib (ELTN) and Fedratinib (FDTN) Toward the Treatment of ELTN-Resistant Non-small Cell Lung Cancer (NSCLC) via Suppression of the JAK2/STAT3 Signaling Pathway
doi 10.3389/fphar.2018.01214
- 4,271 views
- 40 citations
